358 related articles for article (PubMed ID: 26828466)
1. Preventive and Therapeutic Effects of Chinese Herbal Compounds against Hepatocellular Carcinoma.
Hu B; An HM; Wang SS; Chen JJ; Xu L
Molecules; 2016 Jan; 21(2):142. PubMed ID: 26828466
[TBL] [Abstract][Full Text] [Related]
2. Chinese herbal medicine-derived compounds for cancer therapy: a focus on hepatocellular carcinoma.
Hu Y; Wang S; Wu X; Zhang J; Chen R; Chen M; Wang Y
J Ethnopharmacol; 2013 Oct; 149(3):601-12. PubMed ID: 23916858
[TBL] [Abstract][Full Text] [Related]
3. Preventive and therapeutic role of traditional Chinese herbal medicine in hepatocellular carcinoma.
Ting CT; Li WC; Chen CY; Tsai TH
J Chin Med Assoc; 2015 Mar; 78(3):139-44. PubMed ID: 25447209
[TBL] [Abstract][Full Text] [Related]
4. Role of MicroRNAs Induced by Chinese Herbal Medicines Against Hepatocellular Carcinoma: A Brief Review.
Guo G; Zhou J; Yang X; Feng J; Shao Y; Jia T; Huang Q; Li Y; Zhong Y; Nagarkatti PS; Nagarkatti M
Integr Cancer Ther; 2018 Dec; 17(4):1059-1067. PubMed ID: 30343602
[TBL] [Abstract][Full Text] [Related]
5. (-)-Oleocanthal inhibits growth and metastasis by blocking activation of STAT3 in human hepatocellular carcinoma.
Pei T; Meng Q; Han J; Sun H; Li L; Song R; Sun B; Pan S; Liang D; Liu L
Oncotarget; 2016 Jul; 7(28):43475-43491. PubMed ID: 27259268
[TBL] [Abstract][Full Text] [Related]
6. I
Wu L; Sun B; Lin X; Liu C; Qian H; Chen L; Yang Y; Shen F; Su C
Genes Cells; 2018 Jan; 23(1):35-45. PubMed ID: 29210217
[TBL] [Abstract][Full Text] [Related]
7. 3-bromopyruvate and buthionine sulfoximine effectively kill anoikis-resistant hepatocellular carcinoma cells.
Lee M; Jo A; Lee S; Kim JB; Chang Y; Nam JY; Cho H; Cho YY; Cho EJ; Lee JH; Yu SJ; Yoon JH; Kim YJ
PLoS One; 2017; 12(3):e0174271. PubMed ID: 28362858
[TBL] [Abstract][Full Text] [Related]
8. Targeting Tumor Immunosuppressive Microenvironment for the Prevention of Hepatic Cancer: Applications of Traditional Chinese Medicines in Targeted Delivery.
Zhang LY; Zhang JG; Yang X; Cai MH; Zhang CW; Hu ZM
Curr Top Med Chem; 2020; 20(30):2789-2800. PubMed ID: 33076809
[TBL] [Abstract][Full Text] [Related]
9. [Effects of the Chinese herbal extract Songyou Yin on the residual hepatocellular carcinoma after chemotherapy in nude mice].
Xiong W; Tang ZY; Ren ZG; Huang XY; Jia QA; Xie XY; Shen HJ
Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):804-7. PubMed ID: 24447475
[TBL] [Abstract][Full Text] [Related]
10. Mannose-mediated inhibitory effects of PA-MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR/Akt/IκBβ/NF-κB pathway.
Li T; Dong ZR; Guo ZY; Wang CH; Zhi XT; Zhou JW; Li DK; Chen ZT; Chen ZQ; Hu SY
Liver Int; 2015 Apr; 35(4):1416-29. PubMed ID: 25066210
[TBL] [Abstract][Full Text] [Related]
11. Traditional Chinese herbal medicines for treatment of liver fibrosis and cancer: from laboratory discovery to clinical evaluation.
Luk JM; Wang X; Liu P; Wong KF; Chan KL; Tong Y; Hui CK; Lau GK; Fan ST
Liver Int; 2007 Sep; 27(7):879-90. PubMed ID: 17696925
[TBL] [Abstract][Full Text] [Related]
12. Chinese herbal medicine and chemotherapy in the treatment of hepatocellular carcinoma: a meta-analysis of randomized controlled trials.
Shu X; McCulloch M; Xiao H; Broffman M; Gao J
Integr Cancer Ther; 2005 Sep; 4(3):219-29. PubMed ID: 16113029
[TBL] [Abstract][Full Text] [Related]
13. A Case of Recurrent Hepatocellular Carcinoma Acquiring Complete Remission of Target Lesion With Treatment With Traditional Chinese Medicine.
Jianxin C; Qingxia X; Junhui W; Qinhong Z
Integr Cancer Ther; 2017 Dec; 16(4):597-604. PubMed ID: 27444311
[TBL] [Abstract][Full Text] [Related]
14. Osthole inhibits the tumorigenesis of hepatocellular carcinoma cells.
Lin ZK; Liu J; Jiang GQ; Tan G; Gong P; Luo HF; Li HM; Du J; Ning Z; Xin Y; Wang ZY
Oncol Rep; 2017 Mar; 37(3):1611-1618. PubMed ID: 28184928
[TBL] [Abstract][Full Text] [Related]
15. Anticancer effects of crude extract from Melia toosendan Sieb. et Zucc on hepatocellular carcinoma in vitro and in vivo.
Liu XL; Wang H; Zhang L; Wang YL; Wang J; Wang P; He X; He YJ
Chin J Integr Med; 2016 May; 22(5):362-9. PubMed ID: 26383159
[TBL] [Abstract][Full Text] [Related]
16. Metformin sensitizes sorafenib to inhibit postoperative recurrence and metastasis of hepatocellular carcinoma in orthotopic mouse models.
You A; Cao M; Guo Z; Zuo B; Gao J; Zhou H; Li H; Cui Y; Fang F; Zhang W; Song T; Li Q; Zhu X; Yin H; Sun H; Zhang T
J Hematol Oncol; 2016 Mar; 9():20. PubMed ID: 26957312
[TBL] [Abstract][Full Text] [Related]
17. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X
Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740
[TBL] [Abstract][Full Text] [Related]
18. Novel phyto-derivative BRM270 inhibits hepatocellular carcinoma cells proliferation by inducing G2/M phase cell cycle arrest and apoptosis in xenograft mice model.
Kumar Mongre R; Sharma N; Singh Sodhi S; Ghosh M; Kumar Singh A; Kim N; Park YH; Shin YG; Kim SJ; Jiao Jiao Z; Huynh DL; Jeong DK
Biomed Pharmacother; 2017 Mar; 87():741-754. PubMed ID: 28110264
[TBL] [Abstract][Full Text] [Related]
19. Prognostic analysis of transarterial chemoembolization combined with a traditional Chinese herbal medicine formula for treatment of unresectable hepatocellular carcinoma.
Yu Y; Lang QB; Chen Z; Li B; Yu CQ; Zhu DZ; Huang XQ; Zhai XF; Ling CQ
Chin Med J (Engl); 2009 Sep; 122(17):1990-5. PubMed ID: 19781383
[TBL] [Abstract][Full Text] [Related]
20. Updates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implications.
García-Vilas JA; Medina MÁ
World J Gastroenterol; 2018 Sep; 24(33):3695-3708. PubMed ID: 30197476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]